JIM
MJN

Jupiter Investment Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Jupiter Investment Management’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,800
Closed -$516K – 523
2017
Q1 		$516K Buy
+5,800
New +$477K 0.01% 281
2015
Q4 		– Sell
-312,596
Closed -$22M – 400
2015
Q3 		$22M Buy
+312,596
New +$25.7M 0.62% 53

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Jupiter Investment Management's MJN Position: Q2 2017 in Review

Jupiter Investment Management sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 5,800 shares — an estimated $516K sold.

Jupiter Investment Management first reported a position in MJN in Q3 2015 and held it in 2 quarters. The position peaked at $22M in Q3 2015. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Jupiter Investment Management reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Jupiter Investment Management sold 5,800 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $516K.
  • Jupiter Investment Management first reported a position in Mead Johnson Nutrition Company in Q3 2015 and held it in 2 quarters.
  • Jupiter Investment Management's Mead Johnson Nutrition Company position peaked at $22M in Q3 2015.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Jupiter Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.